Company

Hansa Biopharma

2022

Quick facts

6,283

Emissions (ton CO₂e)

14.83

Revenue (M USD)

423.57

Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Hansa Biopharma reported a total of 6,283 ton CO₂e, and a net revenue of 14.83 M USD, resulting in a emissions intensity of 423.57 t CO₂e / M USD.

Targets

(No target data available)

Emissions, Revenue & Intensity

(No target data available to show graph)

Revenue	2022
Net Revenue (M USD)	14.83
Revenue Source

Emissions Overview	2022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)	423.57
Cradle-to-gate Intensity (t CO₂e / M USD)	423.57

Emissions Details	2022
Scope 1	7
Scope 2
Scope 2 - Location Based	82
Scope 2 - Market Based
Scope 2 - Not specified
Scope 3	6,194
Upstream Emissions
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions	6,283
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0